Quantcast

Latest Organic chemistry Stories

2014-09-24 23:00:43

In its latest blog post, A Forever Recovery, an open-ended drug and alcohol treatment program that gets clients off to a great start and gives them a solid foundation in recovery they can believe in, is focusing on key facts about the history of oxycodone. Battle Creek, MI (PRWEB) September 25, 2014 In its latest blog post, A Forever Recovery, an open-ended drug and alcohol treatment program that gets clients off to a great start and gives them a solid foundation in recovery they can...

2014-09-24 08:29:17

National Fed Up! Coalition Holds Second Major Rally as Death Toll Climbs from Opioid Epidemic WASHINGTON, Sept. 24, 2014 /PRNewswire-USNewswire/ -- On Sunday, September 28, 2014, a coalition of consumer advocacy organizations, drug prevention groups, medical experts and addiction treatment providers will hold the second annual Fed Up! Rally to call for an immediate, coordinated and comprehensive federal response to the epidemic of opioid addiction and overdose deaths. The Rally will...

2014-09-24 08:28:08

95 of 180 Patients Enrolled; Additional Patients Screened, Awaiting Randomization PRINCETON, N.J., Sept. 24, 2014 /PRNewswire/ -- Braeburn Pharmaceuticals today announced that it has surpassed the midway point for patient enrollment in its Phase 3 study of Probuphine(®), which began in July of 2014. Probuphine is a buprenorphine subdermal implant being studied for the maintenance treatment of opioid dependence. Completion of the study is on track for the middle of 2015, with...

2014-09-24 04:21:41

WHIPPANY, N.J., Sept. 24, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. announced today that data from its oncology portfolio, including Stivarga(®) (regorafenib) tablets, NEXAVAR(®) (sorafenib) tablets and Xofigo(®) (radium Ra 223 dichloride) injection, will be presented at the European Society for Medical Oncology (ESMO) 2014 Congress taking place September 26 - 30 in Madrid, Spain. "Bayer's presence at this global medical congress demonstrates our commitment to research...

2014-09-23 23:02:39

The Firm is representing numerous Risperdal lawsuit plaintiffs who allegedly suffered gynecomastia (male breast growth) due to their use of the antipsychotic medication. New York, New York (PRWEB) September 23, 2014 Risperdal lawsuits (http://www.drugbot.com/risperdal/lawsuit/) continue to move forward in courts around the country, Bernstein Liebhard LLP reports. According to an Order issued in U.S. District Court, Middle District of Florida on September 19th, the Court has dismissed...

2014-09-23 23:00:20

Menopause can cause symptoms similar to depression; Pristiq can help. Houston, TX (PRWEB) September 24, 2014 Menopause can cause symptoms similar to depression; Pristiq can help. For roughly half of women, menopause can trigger debilitating fluctuations in hormone levels, bringing on symptoms more commonly associated with major depressive disorder. These include intense feelings of hopelessness, anxiety, irritability, sleep disturbances, memory loss, and fatigue. While hormone therapies...

2014-09-23 12:30:04

WAISMANN METHOD® Medical Director Urges Targeted Prevention Strategies and Prompt Treatment to Slow Prescription Painkiller Overdose Epidemic BEVERLY HILLS, Calif., Sept. 23, 2014 /PRNewswire/ -- Michael H. Lowenstein M.D., medical director for the Waismann Method opiate treatment, warns that opioid overdose rates continue to rise, albeit at a slower rate. Photo - http://photos.prnewswire.com/prnh/20140922/147564 Overdose deaths associated with prescription painkillers increased...

2014-09-23 08:31:03

KemPharm Joins CLADD in Support of Legislation from Health Canada to Encourage More Responsible Development and Administration of Prescription Opioids CORALVILLE, Iowa, Sept. 23, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity (NME) prodrugs, announced today that it received a No Objection Letter (NOL) from Health Canada to begin clinical trials in Canada for its lead...

2014-09-21 23:01:43

LifeScienceIndustryResearch.com adds Latest Report on “Market Research Report on Global and Chinese Fenofibrate (CAS 49562-28-9) Industry, 2009-2019” to its store. Inquire Before Buying at http://www.lifescienceindustryresearch.com/inquire-before-buying?rname=12380 Dallas, TX (PRWEB) September 21, 2014 Market Research Report on Global and Chinese Fenofibrate (CAS 49562-28-9) Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Fenofibrate (CAS...

2014-09-21 23:01:32

The Firm is representing numerous Risperdal lawsuit plaintiffs who have filed cases in Pennsylvania that allege the drug caused gynecomastia (male breast growth). New York, New York (PRWEB) September 21, 2014 Hundreds of Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) continue to move forward in Pennsylvania’s Philadelphia Court of Common Pleas, Bernstein Liebhard LLP reports. According to court documents, the proceeding’s next monthly meeting has been scheduled for...


Latest Organic chemistry Reference Libraries

Organometallics
2012-05-17 15:18:17

Organometallics is a peer-reviewed scientific journal published by the American Chemical Society. As of May 2012, the editor-in-chief is John A. Gladysz. Organometallics publishes records in one of the most active fields for organometallic, inorganic, organic, and materials chemists. Articles, communications, mini-reviews, and notes detail the synthesis, structure, bonding, chemical reactivity and reaction mechanisms, and applications of organometallic and organometalloidal compounds....

Synthetic Metals
2012-05-17 14:54:38

Synthetic Metals is a peer-reviewed scientific journal published by Elsevier. It covers all aspects of electronic polymers and electronic molecular materials. It is an international medium for the rapid publication of original research papers, short communications and subject reviews dealing with research on and applications of electronic polymers and electronic molecular materials including novel carbon architectures. Original manuscripts on chemical, electrochemical, electrical, photonic...

More Articles (2 articles) »
Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related